India plans to restrict vaccine and biologics testing exclusively to government laboratories, according to officials and documents reviewed by Mint. The Central Drugs Standard Control Organization will mandate manufacturers route batch testing through authorized government institutions like the National Institute of Biologicals in Noida. Currently, 350-400 private labs test drugs. The policy shift aims to maintain quality standards and ensure uniformity across testing platforms.